Welcome to our dedicated page for SI-BONE SEC filings (Ticker: SIBN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on SI-BONE's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into SI-BONE's regulatory disclosures and financial reporting.
SI-BONE, Inc. (SIBN) – Form 4 filing dated 07/07/2025
Senior Vice President, Operations & Administration and Chief Legal Officer Michael A. Pisetsky reported a routine “sell-to-cover” transaction tied to the vesting of restricted stock units (RSUs) on 07/02/2025. To satisfy withholding taxes, Pisetsky sold an aggregate 3,127 common shares in three market transactions at weighted-average prices between $18.26 – $18.38 per share.
Following the sales, the executive retains 261,681 common shares, which includes 145,043 shares underlying un-settled RSUs. No derivative securities were involved, and the filing states the sales were non-discretionary and solely for tax purposes.
The disposition represents approximately 1.2 % of the executive’s post-transaction holdings and does not alter overall insider ownership meaningfully. There is no indication of strategic intent or change in outlook for SIBN; the filing is considered administratively routine under Section 16 rules.